ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
NovoSeven 5 mg, raumtemperaturstabiles Injektionspräparat - Set(s)
58693007 Novo Nordisk Pharma AG
NovoSeven 5 mg, raumtemperaturstabiles Injektionspräparat27.03.2009
  27.03.2009
Coagulation Factor Viia (B02BD08) 
WHO-DDD 
06.01.10.Set(s)
06.01.10. 
B  
Yes 
IPCI
4224.20Yes
    
10 %4375.05
  
7680586930071Biotechnologika
5621505 
Composition
Praeparatio cryodesiccata: eptacogum alfa (activatum) 5 mg, natrii chloridum, calcii chloridum dihydricum, glycyl-glycinum, polysorbatum 80, saccharum, mannitolum, antiox.: methioninum 2.5 mg, pro vitro. Solvens: histidinum, aqua ad iniectabile q.s. ad solutionem pro 5.17 ml. Solutio reconstituta: eptacogum alfa (activatum) 5 mg, saccharum, aqua ad iniectabile q.s. ad solutionem pro 5 ml.
Packungsbestandteile
Praeparatio cryodesiccata:
 
Injection preparation, stable at room temperature 
  
 
Active AgentDose
Eptacog Alfa5 mg
BAG: Active AgentDose
Eptacog Alfa5 mg
 
Inactive agentsDoseadditional_information
Calcium Chloride  
Glycyl-Glycinum  
Mannitol  
Methionine2.5 mgantiox.
Sodium Chloride  
Polysorbatum 80  
Saccharum  
 
Solvens
 
Injection preparation, stable at room temperature 
  
  
BAG: Active AgentDose
Eptacog Alfa5 mg
 
Inactive agents
Histidine
 
Source
Data was imported : 07.10.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home